Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Denardo

Showing results (31-40 of 101) with videos related to

Pageof 11
Sort By:
Gut|May 12, 2019
Development of resistance to FAK inhibition in pancreatic cancer is linked to stromal depletionHong Jiang, Xiuting Liu, Brett L Knolhoff, et al.
Cancer Research|September 16, 2010
Macrophage expression of hypoxia-inducible factor-1 alpha suppresses T-cell function and promotes tumor progressionAndrew L Doedens, Christian Stockmann, Mark P Rubinstein, et al.
Genes & Development|September 26, 2013
Cathepsin C is a tissue-specific regulator of squamous carcinogenesisBrian Ruffell, Nesrine I Affara, Lucia Cottone, et al.
Nature Communications|December 30, 2025
Chemotherapy-induced adipo-lineage cell senescence drives bone lossGanesh Kumar Raut, Taylor Malachowski, Anupama Melam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 28, 2011
MRI of tumor-associated macrophages with clinically applicable iron oxide nanoparticlesHeike E Daldrup-Link, Daniel Golovko, Brian Ruffell, et al.
Cancer Research|August 2, 2014
CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer modelsYu Zhu, Brett L Knolhoff, Melissa A Meyer, et al.
Frontiers in Immunology|December 26, 2022
Combination TIGIT/PD-1 blockade enhances the efficacy of neoantigen vaccines in a model of pancreatic cancerHui Peng, Lijin Li, Chong Zuo, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Targeting tumor-intrinsic TAK1 triggers anti-tumor immunity and sensitizes pancreatic cancer to checkpoint blockadeSapana P Bansod, Timothy Hung-Po Chen, Vikas K Somani, et al.
Oncoimmunology|September 20, 2018
Recruitment of CCR2<sup>+</sup> tumor associated macrophage to sites of liver metastasis confers a poor prognosis in human colorectal cancerJulie G Grossman, Timothy M Nywening, Brian A Belt, et al.
Oncoimmunology|March 20, 2024
Intratumoral T-cell receptor repertoire composition predicts overall survival in patients with pancreatic ductal adenocarcinomaVikram S Pothuri, Graham D Hogg, Leah Conant, et al.
Pageof 11

Showing results (31-40 of 101) with videos related to

Sort By:
Pageof 11
Gut|May 12, 2019
Development of resistance to FAK inhibition in pancreatic cancer is linked to stromal depletionHong Jiang, Xiuting Liu, Brett L Knolhoff, et al.
Cancer Research|September 16, 2010
Macrophage expression of hypoxia-inducible factor-1 alpha suppresses T-cell function and promotes tumor progressionAndrew L Doedens, Christian Stockmann, Mark P Rubinstein, et al.
Genes & Development|September 26, 2013
Cathepsin C is a tissue-specific regulator of squamous carcinogenesisBrian Ruffell, Nesrine I Affara, Lucia Cottone, et al.
Nature Communications|December 30, 2025
Chemotherapy-induced adipo-lineage cell senescence drives bone lossGanesh Kumar Raut, Taylor Malachowski, Anupama Melam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 28, 2011
MRI of tumor-associated macrophages with clinically applicable iron oxide nanoparticlesHeike E Daldrup-Link, Daniel Golovko, Brian Ruffell, et al.
Cancer Research|August 2, 2014
CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer modelsYu Zhu, Brett L Knolhoff, Melissa A Meyer, et al.
Frontiers in Immunology|December 26, 2022
Combination TIGIT/PD-1 blockade enhances the efficacy of neoantigen vaccines in a model of pancreatic cancerHui Peng, Lijin Li, Chong Zuo, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Targeting tumor-intrinsic TAK1 triggers anti-tumor immunity and sensitizes pancreatic cancer to checkpoint blockadeSapana P Bansod, Timothy Hung-Po Chen, Vikas K Somani, et al.
Oncoimmunology|September 20, 2018
Recruitment of CCR2<sup>+</sup> tumor associated macrophage to sites of liver metastasis confers a poor prognosis in human colorectal cancerJulie G Grossman, Timothy M Nywening, Brian A Belt, et al.
Oncoimmunology|March 20, 2024
Intratumoral T-cell receptor repertoire composition predicts overall survival in patients with pancreatic ductal adenocarcinomaVikram S Pothuri, Graham D Hogg, Leah Conant, et al.
Pageof 11